Asthma Spacers Are Fastest Growing Segment Fueling The Growth Of Asthma Spacers Market
Asthma Spacers Are Fastest Growing Segment Fueling The Growth Of Asthma Spacers Market
The global Asthma Spacers Market is estimated to be valued at US$ 1.86 Bn in 2023 and is expected to exhibit a CAGR of 6.7%

The global Asthma Spacers Market is estimated to be valued at US$ 1.86 Bn in 2023 and is expected to exhibit a CAGR of 6.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

 

Market Overview

 

Asthma spacers are devices used with pressurized, metered-dose inhalers (MDIs) to help deliver medication to the lungs. They allow patients to inhale medication from an MDI more effectively and help reduce common errors such as exhalation into the spacer or coordinating actuations with inhalation.

 

Market key trends

 

One of the key trends in the asthma spacers market is the growing demand for portable and easy-to-use asthma spacers. With increasingly hectic lifestyles, there is demand for products that can be carried easily and used on-the-go without difficulty. This has prompted manufacturers to develop compact, lightweight asthma spacers that can be carried in bags or pockets. Integrated dose counters are another trend as they help patients track remaining doses and ensure medication adherence. Adoption of digital technologies and sensors to aid remote monitoring is also gaining ground in the market.

 

Segment Analysis

 

The global asthma spacers market has been segmented by product, disease type, distribution channel, end user, and region. By product, the market is divided into aerochamber, optichamber, volumatic, inspirae, and others. The aerochamber segment dominates the market and accounted for approximately 30% share in 2022. Aerochamber spacers are highly effective in medication delivery, economical, and helps improve medication adherence among asthma patients.

 

Key Takeaways

 

The global Asthma Spacers Market Share is expected to witness high growth, exhibiting CAGR of 6.7% over the forecast period, due to increasing prevalence of asthma worldwide. By 2030, 339 million people are expected to be suffering from asthma globally.

 

Regional analysis

North America dominated the global market and accounted for over 35% market share in 2022 owing to growing geriatric population, rising pollution and allergies leading to asthma, and presence of well-established healthcare facilities in the region. The Asia Pacific region is expected to grow at the fastest CAGR during the forecast period due to large patient population, increasing healthcare expenditure, and rising awareness about asthma management.

 

Key players

Key players operating in the asthma spacers market are Trudell Medical International, PARI Respiratory Equipment, Inc., Koninklijke Philips N.V, GlaxoSmithKline Plc., Lupin, Medical Developments International, Visiomed Group Ltd., Cipla Inc., Clement Clarke International Ltd., Rossmax International Ltd., Luckys Pharma, Mediacare Equipments (India) Pvt. Ltd., Asia Connection Co., Ltd., and Laboratoire Protecsom SAS.

 

Get More Insights On This Topic: https://www.ukwebwire.com/boost-the-growth-of-asthma-spacers-market-share-trends-analysis/

 

What's your reaction?

Comments

https://www.timessquarereporter.com/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!

Facebook Conversations